Le Lézard
Classified in: Health
Subject: AWD

AAOMS honors oral and maxillofacial surgeons during Annual Meeting


SAN FRANCISCO, Oct. 13, 2017 /PRNewswire-USNewswire/ -- More than 20 oral and maxillofacial surgeons were honored by the American Association of Oral and Maxillofacial Surgeons (AAOMS) for contributing to the specialty through their exceptional research, education and advocacy.

The experts in face, mouth and jaw surgery(TM) - The American Association of Oral and Maxillofacial Surgeons (AAOMS), the professional organization representing more than 9,500 oral and maxillofacial surgeons in the United States, supports its fellows' and members' ability to practice their specialty through education, research and advocacy. AAOMS fellows and members comply with rigorous continuing education requirements and submit to periodic office anesthesia evaluations. Visit MyOMS.org for additional information about oral and facial surgery.

Awards were presented Oct. 11 during the Opening Ceremony of the 99th AAOMS Annual Meeting ? the largest gathering of oral and maxillofacial surgeons in the country.

The Annual Meeting was dedicated to William H. Bell, DDS, of Stowe, Vt., posthumously, for his vital research on the Le Fort I osteotomy ? one of the most commonly used procedures to correct midface deformities. He also is credited for contributing to the specialty's movement from oral surgery to oral and maxillofacial surgery.  

AAOMS presented its top award ? the Robert V. Walker Distinguished Service Award ? to Thomas Dodson, DMD, MPH, FACS, of Seattle, Wash., for his clinical research that has benefited patients and cultivated innovations in the practice of oral and maxillofacial surgery. Dr. Dodson has authored more than 100 peer-reviewed articles, covering topics from office-based anesthesia and wisdom teeth extraction outcomes to identifying victims of domestic abuse with clinical markers.  

Other award winners include:

The experts in face, mouth and jaw surgery® ? The American Association of Oral and Maxillofacial Surgeons (AAOMS) is the professional organization representing more than 11,000 oral and maxillofacial surgeons, OMS residents and OMS professional staff in the United States. AAOMS supports its fellows' and members' ability to practice their specialty through education, research and advocacy. AAOMS fellows and members comply with rigorous continuing education requirements and submit to periodic office anesthesia evaluations. For additional information about oral and maxillofacial surgery, visit the AAOMS websites at AAOMS.org and myOMS.org.

SOURCE American Association of Oral & Maxillofacial Surgeons


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: